This announcement follows OptumRx’s series of measures to promote transparent drug pricing amid growing scrutiny over the role of PBMs in escalating healthcare costs in the United States.

Also Read: UnitedHealth’s OptumRx Unveils New Transparent Drug Pricing Initiative for 2024. The U.S. Drug Enforcement Administration (DEA) investigated OptumRx’s practices, revealing that a ...